NCT01669291View on ClinicalTrials.gov

Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Fertility
Interventions
DRUG

Bravelle and Menopur

Bravelle and Menopur are used for controlled ovarian stimulation (COH)

DRUG

Agonist

Agonist (Lupron) is used to suppress endogenous pituitary LH for the premature LH surges.

DRUG

Antagonist

Ganirelix acetate or cetrorelix acetate Agonist is used to suppress endogenous pituitary LH for the premature LH surges.

Trial Locations (1)

19010

Main Line Fertility Center, Bryn Mawr

Sponsors

Collaborators (1)

Ferring Pharmaceuticals
All Listed Sponsors
collaborator

Ferring Pharmaceuticals

INDUSTRY

lead

Main Line Fertility Center

OTHER

NCT01669291 - Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation | Biotech Hunter | Biotech Hunter